Work

Tau: From research to clinical development

Year: 2016

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1016/j.jalz.2016.03.018

Authors: David M. Holtzman, Maria C. Carrillo, James A. Hendrix, Lisa J. Bain, Ana M. Catafau, Laura M. Gault, Michel Goedert, Eckhard Mandelkow, Eva‐Maria Mandelkow, David S. Miller, Susanne Ostrowitzki, Manuela Polydoro, Sean Smith, Marion Wittmann, Michael Hutton

Institutions: Washington University in St. Louis, Hope Center for Neurological Disorders, Alzheimer's Association, Piramal (Germany), AbbVie (United States), MRC Laboratory of Molecular Biology, Medical Research Council, Center of Advanced European Studies and Research, German Center for Neurodegenerative Diseases, Roche (Switzerland), Merck & Co., Inc., Rahway, NJ, USA (United States), Biogen (United States), Eli Lilly (United Kingdom)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: JPB Foundation, National Institutes of Health, Tau Consortium

Awards: G5383363182, G9000083070

OpenAlex ID: W2345948651

FWCI: 13.68

Cites: 64

Cited by: 139

Related to: 10